Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Amos D. Korczyn »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Amir Glik < Amos D. Korczyn < Amos Korczyn  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000314 (2007) Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada]Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
000371 (2006) Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni]Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa
000561 (1998) Rascol [France] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Amos D. Korczyn [Israël] ; Warner H. Poewe [Autriche] ; Fabrizzio Stocchi [Italie]Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study

List of associated KwdEn.i

Nombre de
documents		Descripteur
3Humans
3Levodopa
3Parkinson Disease (drug therapy)
3Ropinirole
2Aged
2Antiparkinson Agents (adverse effects)
2Antiparkinson Agents (therapeutic use)
2Confidence Intervals
2Disease Progression
2Double-Blind Method
2Dyskinesia
2Female
2Indoles (adverse effects)
2Indoles (therapeutic use)
2Levodopa (adverse effects)
2Levodopa (therapeutic use)
2Longitudinal Studies
2Male
2Middle Aged
2Nervous system diseases
2Parkinson disease
2Parkinson's disease
2Treatment Outcome
2dyskinesia
2levodopa
2ropinirole
1Adult
1Amantadine (adverse effects)
1Amantadine (therapeutic use)
1Analysis of Variance
1Complication
1Disability Evaluation
1Dopamine Agonists (therapeutic use)
1Dopamine agonist
1Double‐blind, controlled study
1Drug Therapy, Combination
1Dyskinesia, Drug-Induced (etiology)
1Dyskinesia, Drug-Induced (mortality)
1Early Parkinson's disease
1Follow-Up Studies
1Human
1Odds Ratio
1Parkinson Disease (epidemiology)
1Parkinson Disease (mortality)
1Parkinson Disease (physiopathology)
1Predictive Value of Tests
1Proportional Hazards Models
1Regression Analysis
1Risk Factors
1Severity of Illness Index
1Survival Analysis
1Treatment
1dopamine agonist
1motor complications
1treatment
1wearing off

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Amos D. Korczyn" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Amos D. Korczyn" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Amos D. Korczyn
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024